AbbVie Current Ratio 2010-2018 | ABBV

Historical current ratio values for AbbVie (ABBV) over the last 10 years.
AbbVie Annual Current Ratio
2017 1.28
2016 1.66
2015 1.50
2014 1.41
2013 2.60
2012 2.27
2011 1.25
2010 2.19
2009 0.00
AbbVie Quarterly Current Ratio
Q2 2018 0.80
Q1 2018 1.20
Q4 2017 1.28
Q3 2017 1.45
Q2 2017 1.38
Q1 2017 1.76
Q4 2016 1.66
Q3 2016 1.79
Q2 2016 1.81
Q1 2016 1.56
Q4 2015 1.50
Q3 2015 2.03
Q2 2015 1.50
Q1 2015 1.39
Q4 2014 1.41
Q3 2014 2.65
Q2 2014 2.82
Q1 2014 2.79
Q4 2013 2.60
Q3 2013 2.41
Q2 2013 2.30
Q1 2013 2.21
Q4 2012 2.27
Q3 2012 2.04
Q2 2012 1.24
Q1 2012 1.22
Q4 2011 1.25
Q3 2011 0.00
Q2 2011 0.00
Q1 2011 0.00
Q4 2010 0.00
Q4 2009 0.00
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $149.625B $28.216B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $360.770B 17.24
Pfizer (PFE) United States $250.556B 14.67
Novartis AG (NVS) Switzerland $192.442B 16.51
Merck (MRK) United States $186.199B 16.44
Novo Nordisk (NVO) Denmark $115.970B 18.54
Eli Lilly (LLY) United States $113.359B 20.98
Sanofi (SNY) France $105.440B 13.35
GlaxoSmithKline (GSK) United Kingdom $102.297B 13.66
Bristol-Myers Squibb (BMY) United States $99.527B 18.01
AstraZeneca (AZN) United Kingdom $96.554B 10.62